BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Amyloidosis Africa - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://amyloidosisafrica.org
X-WR-CALDESC:Events for Amyloidosis Africa
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20250801T080000
DTEND;TZID=Africa/Nairobi:20260801T170000
DTSTAMP:20260406T184536
CREATED:20260217T113656Z
LAST-MODIFIED:20260227T095602Z
UID:14941-1754035200-1785603600@amyloidosisafrica.org
SUMMARY:ATTR Cardiac Amyloidosis CPD-Accredited CME
DESCRIPTION:This CPD-accredited online course is designed to enhance the knowledge\, diagnostic accuracy\, and clinical response of healthcare professionals in Kenya regarding transthyretin (TTR) cardiac amyloidosis\, a serious and underrecognized cause of heart failure. Through an evidence-based and locally contextualized curriculum\, the course empowers clinicians to identify red flags\, select and interpret appropriate diagnostic tools\, and apply best-practice management strategies\, including genetic counseling and advanced imaging. \nParticipants will engage with dynamic learning modules\, animated explainer videos\, expert interviews\, and real-world clinical cases to sharpen diagnostic reasoning and multidisciplinary collaboration. The course also introduces emerging therapies and surveillance strategies tailored to both wild-type and hereditary forms of ATTR-CM. \nWhether you’re a cardiologist\, internal medicine specialist\, radiologist\, lab expert\, or front-line provider\, this course equips you with the tools to ensure earlier diagnosis\, improve patient outcomes\, and bridge critical gaps in care across Kenya. \nFor Medical Doctor CPD: icpd kenya
URL:https://amyloidosisafrica.org/event/attr-cardiac-amyloidosis/
LOCATION:CRK Courses Platform\, Kenya
ATTACH;FMTTYPE=image/webp:https://amyloidosisafrica.org/wp-content/uploads/2026/02/New-Project-1-4.webp
ORGANIZER;CN="CRK CLINICAL RESEARCH KEY NGO":MAILTO:contact@clinicalresearchkey.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260227T080000
DTEND;TZID=UTC:20260430T170000
DTSTAMP:20260406T184536
CREATED:20260227T095127Z
LAST-MODIFIED:20260227T095727Z
UID:15863-1772179200-1777568400@amyloidosisafrica.org
SUMMARY:Cardiac Amyloidosis Screening and Management in Patients with Heart Failure: An International African Survey
DESCRIPTION:Introduction \nCardiac amyloidosis (CA) is an underdiagnosed cause of heart failure in Africa. This survey\, coordinated by the Kenya Cardiac Society (KCS) in collaboration with CRK Clinical Research Key (NGO) and partners\, aims to better understand the current awareness\, diagnostic capacity\, and management practices of CA among healthcare providers. The study is part of the KCS Registry Program on Cardiac Amyloidosis Screening and Implementation Science in Kenya\, and its findings will guide future national and regional initiatives. \nPurpose \nThe goal of this survey is to collect information on: \n\nHealthcare professionals’ experience diagnosing and managing cardiac amyloidosis.\nAvailability and use of diagnostic modalities such as echocardiography\, cardiac MRI\, 99mTc-PYP scintigraphy\, and genetic testing.\nAccess to disease-modifying therapies (DMTs) and local referral pathways.\n\nResults will inform the upcoming PREDICT-AMY Kenya Study\, which will evaluate AI-powered ECG screening for cardiac amyloidosis in low-resource settings.\n \n  \nDuration \nThe survey will take approximately 10-12 minutes to complete and will remain open for eight weeks.\nParticipation is voluntary\, and you may choose to withdraw at any time before submission. \nPREDICT-AMY Kenya Study Duration \n18 months \nConfidentiality \nYour responses will remain strictly anonymous. No identifying personal data will be collected. All data will be stored securely and analyzed only in aggregate form by the CRK Clinical Research Key (NGO) Data Management and Biostatistics Team in accordance with Good Clinical Data Management Practices (GCDMP).\nFindings will be used solely for scientific and educational purposes and may be published with proper acknowledgment to the Kenya Cardiac Society Registry.
URL:https://amyloidosisafrica.org/event/international-african-survey/
LOCATION:Amyloidosis Africa
ATTACH;FMTTYPE=image/webp:https://amyloidosisafrica.org/wp-content/uploads/2026/02/doctor-writing-survey-insurance-claim-form-medical-paperwork-document-script-patient-records-test-result-research-hospital-physician-hands-signing-planning-healthcare-e1774253464295.webp
ORGANIZER;CN="Amyloidosis Africa":MAILTO:contact@amyloidosisafrica.org
END:VEVENT
END:VCALENDAR